Form 4 for ALXO ALX ONCOLOGY HOLDINGS INC
Accepted 2026-03-23 00:00:00 ET · period of report 2026-03-19 · accession 0001193125-26-119705 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-23 | 2026-03-19 | ALXO | Lettmann Jason | CEO, Dir | S - Sale | $2.17 | -12.3K | 293.6K | -4% | -$26.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-19 | S | D | 12,311 | $2.17 | 293,609 | D | — | — |